Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Coronavirus COVID-19 in China - statistics & facts

A SARS-like virus, coronavirus SARS-CoV-2 (formally known as 2019-nCoV) spread around the globe since its outbreak in Wuhan city in China. As of the time of writing, about 200 thousand people in Greater China had contracted the coronavirus. Globally, the virus has infected over 188 million people so far and caused about 4.1 million deaths. Like other coronaviruses (CoV) which can mutate and spread from animals to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause fever, respiratory infections, pneumonia, multi-organ failure, and even death in severe cases. The elderly and those with pre-existing chronic health conditions, such as lung or heart disease and diabetes, are the vulnerable and high risk groups. The COVID-19 pandemic has severely affected the economy of the "world's factory".

How did the outbreak start?

In early December in 2019, the first cases were identified from patients with severe pneumonia in the hospitals in Wuhan - the capital city of Huber province. The Huanan Seafood Wholesale Market in Wuhan has been widely considered as the starting point of the outbreak. According to the analysis of The Lancet, around half of 99 surveyed patients had a history of exposure to the market. Similar to SARS and MERS, the novel coronavirus appears to have originated in bats. Coronaviruses that originate in animals are typically not transmissible to humans, however it can happen. It is still not clear how the virus jumped from animals to humans.

How has the Chinese government responded?

To combat the virus, the Chinese government announced a series of measures in late January 2020, including the cancellation of all Chinese New Year celebrations and a strict nationwide lockdown. On February 3, 2020, the 25,000-square-meter Huoshenshan Hospital was built swiftly with a capacity of 1,000 beds to expand the hospital capacity in the epicenter.

On March 11, the World Health Organization officially declared the novel coronavirus a pandemic. A week later, the Chinese government reported no new domestic transmissions for the first time. On March 31, the National Health Commission (NHC) announced that it would begin reporting the infection number of symptom-free individuals who tested positive for coronavirus. After no new deaths reported for first time, China lifted the ten-week lockdown on Wuhan on April 8. Daily life was returning slowly back to normal in the country. There were some small outbreaks in Beijing in June, Xinjiang in July, and some northeastern provinces since the end of 2020. With a swift launch of tracing, testing, and community lockdown strategies, most outbreaks were quickly under control. However, the strict lockdown measures in some cities have led to a rare public outcry over food shortages among residents.

When it comes to vaccination, China is one of the earliest countries which have rolled out a national immunization program. The Chinese government and private institutions have also invested heavily - about 1.4 billion U.S. dollars - in developing vaccines, therapy, and tests. As of September 2020, 11 COVID-19 vaccines developed by domestic drugmakers have begun clinical trials. As of mid-April 2021, China had approved four such vaccines for public use and a fifth for smaller-scale emergency use. Official media announced that China's locally developed mRNA vaccine, ARCoV, might start Phase III clinical trial around early May. In the first half of 2021, China had exported over 500 million doses of its homegrown vaccines to 112 countries and territories.

What are the economic impacts?

The rapid spread of the disease has impacted global business and tourism. International companies, such as Apple, Tesla, and IKEA, shut down their operations in the country during the early local outbreak. With more travel restrictions imposed inside and outside of China, numerous bookings of flights, hotels, and tours have been canceled. Although the majority of companies had been back to normal operation, consumer spending remained weak. The pandemic impact on China’s trade and various industries across the world have been unprecedented, resulting in a plunge in China's GDP growth rate in 2020 - the lowest point over the last decade.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page and our Trend Whitepaper.

Key figures

The most important key figures provide you with a compact summary of the topic of "Coronavirus COVID-19 in China" and take you straight to the corresponding statistics.

COVID-19 in China

Testing and vaccination

Local impact

Interesting statistics

In the following 5 chapters, you will quickly find the 31 most important statistics relating to "Coronavirus COVID-19 in China".

Coronavirus (COVID-19) in China

Dossier on the topic

All important statistics are prepared by our experts – available for direct download as PPT & PDF!
TOP SELLER

Coronavirus COVID-19 in China - statistics & facts

A SARS-like virus, coronavirus SARS-CoV-2 (formally known as 2019-nCoV) spread around the globe since its outbreak in Wuhan city in China. As of the time of writing, about 200 thousand people in Greater China had contracted the coronavirus. Globally, the virus has infected over 188 million people so far and caused about 4.1 million deaths. Like other coronaviruses (CoV) which can mutate and spread from animals to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause fever, respiratory infections, pneumonia, multi-organ failure, and even death in severe cases. The elderly and those with pre-existing chronic health conditions, such as lung or heart disease and diabetes, are the vulnerable and high risk groups. The COVID-19 pandemic has severely affected the economy of the "world's factory".

How did the outbreak start?

In early December in 2019, the first cases were identified from patients with severe pneumonia in the hospitals in Wuhan - the capital city of Huber province. The Huanan Seafood Wholesale Market in Wuhan has been widely considered as the starting point of the outbreak. According to the analysis of The Lancet, around half of 99 surveyed patients had a history of exposure to the market. Similar to SARS and MERS, the novel coronavirus appears to have originated in bats. Coronaviruses that originate in animals are typically not transmissible to humans, however it can happen. It is still not clear how the virus jumped from animals to humans.

How has the Chinese government responded?

To combat the virus, the Chinese government announced a series of measures in late January 2020, including the cancellation of all Chinese New Year celebrations and a strict nationwide lockdown. On February 3, 2020, the 25,000-square-meter Huoshenshan Hospital was built swiftly with a capacity of 1,000 beds to expand the hospital capacity in the epicenter.

On March 11, the World Health Organization officially declared the novel coronavirus a pandemic. A week later, the Chinese government reported no new domestic transmissions for the first time. On March 31, the National Health Commission (NHC) announced that it would begin reporting the infection number of symptom-free individuals who tested positive for coronavirus. After no new deaths reported for first time, China lifted the ten-week lockdown on Wuhan on April 8. Daily life was returning slowly back to normal in the country. There were some small outbreaks in Beijing in June, Xinjiang in July, and some northeastern provinces since the end of 2020. With a swift launch of tracing, testing, and community lockdown strategies, most outbreaks were quickly under control. However, the strict lockdown measures in some cities have led to a rare public outcry over food shortages among residents.

When it comes to vaccination, China is one of the earliest countries which have rolled out a national immunization program. The Chinese government and private institutions have also invested heavily - about 1.4 billion U.S. dollars - in developing vaccines, therapy, and tests. As of September 2020, 11 COVID-19 vaccines developed by domestic drugmakers have begun clinical trials. As of mid-April 2021, China had approved four such vaccines for public use and a fifth for smaller-scale emergency use. Official media announced that China's locally developed mRNA vaccine, ARCoV, might start Phase III clinical trial around early May. In the first half of 2021, China had exported over 500 million doses of its homegrown vaccines to 112 countries and territories.

What are the economic impacts?

The rapid spread of the disease has impacted global business and tourism. International companies, such as Apple, Tesla, and IKEA, shut down their operations in the country during the early local outbreak. With more travel restrictions imposed inside and outside of China, numerous bookings of flights, hotels, and tours have been canceled. Although the majority of companies had been back to normal operation, consumer spending remained weak. The pandemic impact on China’s trade and various industries across the world have been unprecedented, resulting in a plunge in China's GDP growth rate in 2020 - the lowest point over the last decade.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page and our Trend Whitepaper.

Interesting statistics

In the following 5 chapters, you will quickly find the 31 most important statistics relating to "Coronavirus COVID-19 in China".

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Hadley Ward
Hadley Ward
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Ziyan Zhang
Ziyan Zhang
Customer Relations– Contact (Asia)

Mon - Fri, 11:30am - 10pm (IST)

Contact Kisara Mizuno
Kisara Mizuno
Customer Success Manager– Contact (Asia)

Mon - Fri, 9:30am - 5:30pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Catalina Rodriguez
Catalina Rodriguez
Key Account Manager - LAC– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)